Overview

A Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes

Status:
Completed

Trial end date:
2017-06-01

Target enrollment:

Participant gender:

Summary

This is a two-centre, randomised, double-blind, double-dummy, 3-treatment, 3-period cross-over study using a standardised solid meal test in subjects with type 2 diabetes to investigate postprandial glucose control of BioChaperone® Combo compared with Humalog® Mix25 and with simultaneous subcutaneous injections of Humalog® and Lantus® during three separate dosing visits.

Phase:

Phase 1

Details

Lead Sponsor:

Adocia

Treatments:

Biphasic Insulins
Insulin Glargine
Insulin Lispro
Insulin, Isophane